Press Resease

Gene Synthesis Market - Global Industry Analysis

Gene Synthesis Market By Method (Oligonucleotides and Gene Assembly), By Type (Gene Library Synthesis and Custom Gene Synthesis), By Component (Product and Services), and By Application (Research and Development, Diagnosis, Therapeutics, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018–2026

Published Date: 31-May-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4173 Status : Published

Global gene synthesis market expected to generate around USD 21,565 million by 2026, at a CAGR of around 27.1% between 2019 and 2026. Gene synthesis is a synthetic biological procedure conducted via in vitro conditions. In gene synthesis, the DNA is duplicated or synthesized with various chemicals.

Description

The report covers a forecast and an analysis of the gene synthesis market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2026 based on revenue (USD Million). The study includes the drivers and restraints of the gene synthesis market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the gene synthesis market on a global level.

In order to give the users of this report a comprehensive view of the gene synthesis market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Gene Synthesis Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the gene synthesis market by segmenting it on the basis of method, type, component, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2026. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.

Some key players of the global gene synthesis market are ATDBio, ATUM, Bioneer Corporation, BioCat, Blue Heron Biotech, Biomatik, Epoch Life Science, GENEWIZ, Eurofins Genomics, Integrated DNA Technologies, Genscript, Kaneka Eurogentec, ProteoGenix, OriGene Technologies, Shanghai Medicilon, Thermo Fisher Scientific, Synbio Technologies, and Vigene Biosciences.

This report segments the global gene synthesis market into:

Global Gene Synthesis Market: Method Analysis

  • Oligonucleotides
    • Phosphoramidite Reaction Cycle
    • High-Throughput Array-Based Gene Synthesis Technology
    • Ion Semiconductor Sequencing
    • Nanopore Sequencing
  • Gene Assembly
    • Polymerase-Based
      • Dual-Asymmetric (DA) PCR
      • Overlap Extension (OE)
      • Polymerase Cycling Assembly
      • Thermodynamically-Balanced Inside-Out (TBIO)
      • Microchip-Based Multiplex Gene Synthesis
      • Others
    • Ligase-Based
      • Shotgun Ligation
      • Two-Step Ligation and PCR
      • Ligase Chain Reaction
      • Brick-Based
    • Recombinant-Based
      • Sequence and Ligation Independent Cloning (SLIC)
      • Transformation-Associated Recombination
      • BioBrick Assembly

Global Gene Synthesis Market: Type Analysis

  • Gene Library Synthesis
  • Custom Gene Synthesis
    • cDNA
    • Customized Coding Sequences
    • Genomic DNA
    • RNAi Constructs
    • Others

Global Gene Synthesis Market: Component Analysis

  • Product
  • Services

Global Gene Synthesis Market: Application Analysis

  • Research and Development
  • Diagnosis
  • Therapeutics
  • Others

Global Gene Synthesis Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global gene synthesis market, 2016-2026 (USD Million)
    • 2.2. Global gene synthesis market: Snapshot
  •  
  • Chapter 3. Gene Synthesis Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global gene synthesis market drivers: Impact analysis
      • 3.2.2. Gene Synthesis in Synthetic Biology
      • 3.2.3. Benefits of Gene Synthesis over Molecular Cloning
    • 3.3. Market Restraints
      • 3.3.1. Global gene synthesis market restraints: Impact analysis
      • 3.3.2. Cut-throat competition
      • 3.3.3. Lack of a Skilled Workforce
    • 3.4. Opportunities
      • 3.4.1. Use of Microfluidics Technology
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by method
      • 3.6.2. Market attractiveness analysis, by type
      • 3.6.3. Market attractiveness analysis, by component
      • 3.6.4. Market attractiveness analysis, by application
      • 3.6.5. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Gene Synthesis Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global gene synthesis market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New material launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Gene Synthesis Market - Method t Analysis
    • 5.1. Global gene synthesis market: method overview
      • 5.1.1. Global gene synthesis market revenue share, by method, 2018 and 2026
    • 5.2. Oligonucleotides
      • 5.2.1. Global gene synthesis market for oligonucleotides, 2016-2026 (USD Million)
    • 5.3. Sequencing services by type
      • 5.3.1. Global gene synthesis market for gene assembly, 2016-2026 (USD Million)
  •  
  • Chapter 6. Global Gene Synthesis Market - Type Analysis
    • 6.1. Global gene synthesis market: type overview
      • 6.1.1. Global gene synthesis market revenue share, by type, 2018 and 2026
    • 6.2. Gene Library Synthesis
      • 6.2.1. Global gene synthesis market for gene library synthesis, 2016-2026 (USD Million)
    • 6.3. Custom Gene Synthesis
      • 6.3.1. Global gene synthesis market for custom gene synthesis, 2016-2026 (USD Million)
  •  
  • Chapter 7. Global Gene Synthesis Market - Component Analysis
    • 7.1. Global gene synthesis market: component overview
      • 7.1.1. Global gene synthesis market revenue share, by component, 2018 and 2026
    • 7.2. Product
      • 7.2.1. Global gene synthesis market for product, 2016-2026 (USD Million)
    • 7.3. Services
      • 7.3.1. Global gene synthesis market for services, 2016-2026 (USD Million)
  •  
  • Chapter 8. Global Gene Synthesis Market - Application Analysis
    • 8.1. Global gene synthesis market: application overview
      • 8.1.1. Global gene synthesis market revenue share, by application, 2018 and 2026
    • 8.2. Research and Development
      • 8.2.1. Global gene synthesis market for research and development, 2016-2026 (USD Million)
    • 8.3. Diagnosis
      • 8.3.1. Global gene synthesis market for diagnosis, 2016-2026 (USD Million)
    • 8.4. Therapeutics
      • 8.4.1. Global gene synthesis market for therapeutics, 2016-2026 (USD Million)
    • 8.5. Others
      • 8.5.1. Global gene synthesis market for others, 2016-2026 (USD Million)
  •  
  • Chapter 9. Global Gene Synthesis Market - Regional Analysis
    • 9.1. Global gene synthesis market: Regional overview
      • 9.1.1. Global gene synthesis market revenue share, by region, 2018 and 2026
    • 9.2. North America
      • 9.2.1. North America gene synthesis market, 2016-2026 (USD Million)
      • 9.2.2. North America gene synthesis market revenue, by method, 2016-2026 (USD Million)
      • 9.2.3. North America gene synthesis market revenue, by type, 2016-2026 (USD Million)
      • 9.2.4. North America gene synthesis market revenue, by component, 2016-2026 (USD Million)
      • 9.2.5. North America gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.2.6.2. The U.S. gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.2.6.3. The U.S. gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.2.6.4. The U.S. gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.2.7. Canada
        • 9.2.7.1. Canada gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.2.7.2. Canada gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.2.7.3. Canada gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.2.7.4. Canada gene synthesis market revenue, by application, 2016-2026 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe gene synthesis market, 2016-2026 (USD Million)
      • 9.3.2. Europe gene synthesis market revenue, by method, 2016-2026 (USD Million)
      • 9.3.3. Europe gene synthesis market revenue, by type, 2016-2026 (USD Million)
      • 9.3.4. Europe gene synthesis market revenue, by component, 2016-2026 (USD Million)
      • 9.3.5. Europe gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.3.6. UK
        • 9.3.6.1. UK gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.3.6.2. UK gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.3.6.3. UK gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.3.6.4. UK gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.3.7. Germany
        • 9.3.7.1. Germany gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.3.7.2. Germany gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.3.7.3. Germany gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.3.7.4. Germany gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.3.8. France
        • 9.3.8.1. France gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.3.8.2. France gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.3.8.3. France gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.3.8.4. France gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.3.9. Spain
        • 9.3.9.1. Spain gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.3.9.2. Spain gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.3.9.3. Spain gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.3.9.4. Spain gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.3.10. Italy
        • 9.3.10.1. Italy gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.3.10.2. Italy gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.3.10.3. Italy gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.3.10.4. Italy gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.3.11. Rest of Europe
        • 9.3.11.1. Rest of Europe gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.3.11.2. Rest of Europe gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.3.11.3. North America gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.3.11.4. Rest of Europe gene synthesis market revenue, by application, 2016-2026 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific gene synthesis market, 2016-2026 (USD Million)
      • 9.4.2. Asia Pacific gene synthesis market revenue, by method, 2016-2026 (USD Million)
      • 9.4.3. Asia Pacific gene synthesis market revenue, by type, 2016-2026 (USD Million)
      • 9.4.4. Asia Pacific gene synthesis market revenue, by component, 2016-2026 (USD Million)
      • 9.4.5. Asia Pacific gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.4.6. China
        • 9.4.6.1. China gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.4.6.2. China gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.4.6.3. China gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.4.6.4. China gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.4.7. Japan
        • 9.4.7.1. Japan gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.4.7.2. Japan gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.4.7.3. Japan gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.4.7.4. Japan gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.4.8. India
        • 9.4.8.1. India gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.4.8.2. India gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.4.8.3. India gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.4.8.4. India gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.4.9. Southeast Asia
        • 9.4.9.1. Southeast Asia gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.4.9.2. Southeast Asia gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.4.9.3. Southeast Asia gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.4.9.4. Southeast Asia gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.4.10. Rest of Asia Pacific
        • 9.4.10.1. Rest of Asia Pacific gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.4.10.2. Rest of Asia Pacific gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.4.10.3. Rest of Asia Pacific gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.4.10.4. Rest of Asia Pacific gene synthesis market revenue, by application, 2016-2026 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America gene synthesis market, 2016-2026 (USD Million)
      • 9.5.2. Latin America gene synthesis market revenue, by method, 2016-2026 (USD Million)
      • 9.5.3. Latin America gene synthesis market revenue, by type, 2016-2026 (USD Million)
      • 9.5.4. Latin America gene synthesis market revenue, by component, 2016-2026 (USD Million)
      • 9.5.5. Latin America gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.5.6.2. Brazil gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.5.6.3. Brazil gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.5.6.4. Brazil gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.5.7.2. Rest of Latin America gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.5.7.3. Rest of Latin America gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.5.7.4. Rest of Latin America gene synthesis market revenue, by application, 2016-2026 (USD Million)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa gene synthesis market, 2016-2026 (USD Million)
      • 9.6.2. The Middle East and Africa gene synthesis market revenue, by method, 2016-2026 (USD Million)
      • 9.6.3. The Middle East and Africa gene synthesis market revenue, by type, 2016-2026 (USD Million)
      • 9.6.4. The Middle East and Africa gene synthesis market revenue, by component, 2016-2026 (USD Million)
      • 9.6.5. The Middle East and Africa gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.6.6. GCC Countries
        • 9.6.6.1. GCC countries gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.6.6.2. GCC countries gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.6.6.3. GCC countries gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.6.6.4. GCC countries gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.6.7. South Africa
        • 9.6.7.1. South Africa gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.6.7.2. South Africa gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.6.7.3. South Africa gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.6.7.4. South Africa gene synthesis market revenue, by application, 2016-2026 (USD Million)
      • 9.6.8. Rest of MEA
        • 9.6.8.1. Rest of MEA gene synthesis market revenue, by method, 2016-2026 (USD Million)
        • 9.6.8.2. Rest of MEA gene synthesis market revenue, by type, 2016-2026 (USD Million)
        • 9.6.8.3. Rest of MEA gene synthesis market revenue, by component, 2016-2026 (USD Million)
        • 9.6.8.4. Rest of MEA gene synthesis market revenue, by application, 2016-2026 (USD Million)
  •  
  • Chapter 10. Company Profile
    • 10.1. ATDBio
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. ATUM
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. BioCat
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. Biomatik
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Bioneer Corporation
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Blue Heron Biotech
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Epoch Life Sciences
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. Eurofins Genomics
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. GENEWIZ
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. GenScript
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments
    • 10.11. Integrated DNA Technologies
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Product Portfolio
      • 10.11.4. Business Strategy
      • 10.11.5. Recent Developments
    • 10.12. Kaneka Eurogentec
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Product Portfolio
      • 10.12.4. Business Strategy
      • 10.12.5. Recent Developments
    • 10.13. OriGene Technologies
      • 10.13.1. Overview
      • 10.13.2. Financials
      • 10.13.3. Product Portfolio
      • 10.13.4. Business Strategy
      • 10.13.5. Recent Developments
    • 10.14. ProteoGenix
      • 10.14.1. Overview
      • 10.14.2. Financials
      • 10.14.3. Product Portfolio
      • 10.14.4. Business Strategy
      • 10.14.5. Recent Developments
    • 10.15. Shanghai Medicilon
      • 10.15.1. Overview
      • 10.15.2. Financials
      • 10.15.3. Product Portfolio
      • 10.15.4. Business Strategy
      • 10.15.5. Recent Developments
    • 10.16. Synbio Technologies
      • 10.16.1. Overview
      • 10.16.2. Financials
      • 10.16.3. Product Portfolio
      • 10.16.4. Business Strategy
      • 10.16.5. Recent Developments
    • 10.17. Thermo Fischer Scientific
      • 10.17.1. Overview
      • 10.17.2. Financials
      • 10.17.3. Product Portfolio
      • 10.17.4. Business Strategy
      • 10.17.5. Recent Developments
    • 10.18. Vigene Biosciences
      • 10.18.1. Overview
      • 10.18.2. Financials
      • 10.18.3. Product Portfolio
      • 10.18.4. Business Strategy
      • 10.18.5. Recent Developments

Methodology

Free Analysis

Gene synthesis is a synthetic biological procedure conducted via in vitro conditions. In gene synthesis, the DNA is duplicated or synthesized with various chemicals. Gene synthesis provides flexibility to the engineered and synthesized target sequences for any kind of downstream application. Unlike DNA replication that occurs in cells or by the use of PCR (Polymerase Chain Reaction), gene synthesis doesn’t require an initial template strand to start the replication process.

The rising number of R&D activities associated with gene synthesis is mainly fueling the growth of the global gene synthesis market. The increasing investments made by leading companies and government of developing countries in gene synthesis, introduction of new and cost-effective gene synthesis technology, growing awareness about the treatment for genetically inherited diseases, and rising prominence of clinical research to understand biological systems at their core molecular levels are some other factors also fueling the global gene synthesis market.

Global Gene Synthesis Market

The gene synthesis market is fragmented into method, type, component, and application. By method, the gene synthesis market includes oligonucleotides and gene assembly. The oligonucleotide segment is sub-segmented into ion semiconductor sequencing, high-throughput array-based gene synthesis technology, phosphoramidite reaction cycle, and nanopore sequencing. Gene assembly segment is further divided into polymerase-based (PCR, OE, polymerase cycling assembly, TBIO, microchip-based multiplex gene synthesis, and others), ligase-based (shotgun ligation, two-step ligation and PCR, ligase chain reaction, and brick-based), and recombinant-based (transformation-associated recombination, SLIC, and biobrick assembly).  The type segment is divided into custom library synthesis and gene library synthesis. The custom gene synthesis is further sub-segmented into customized coding sequences, RNAi constructs, genomic DNA, cDNA, and others. Based on component, the market is bifurcated into product and services. Based on application, the market includes research and development, therapeutics, diagnosis, and others.

By region, North America is expected to dominate the global gene synthesis market in the future, due to the increasing awareness about the growing prevalence of gene-related diseases, rising research on the treatment of these diseases, and the presence of highly developed research infrastructure. The Asia Pacific gene synthesis market is projected to show the highest growth rate in the upcoming years, owing to the growing investments made by companies and government in gene synthesis research, rising number of biopharmaceutical establishments and biotechnology companies, and increasing numbers of gene tests for the diagnosis of gene-related diseases.

Some key players of the global gene synthesis market are ATDBio, ATUM, Bioneer Corporation, BioCat, Blue Heron Biotech, Biomatik, Epoch Life Science, GENEWIZ, Eurofins Genomics, Integrated DNA Technologies, Genscript, Kaneka Eurogentec, ProteoGenix, OriGene Technologies, Shanghai Medicilon, Thermo Fisher Scientific, Synbio Technologies, and Vigene Biosciences.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social